Elizabeth Colette Tepas, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bronchial Hyperreactivity | 1 | 2006 | 302 | 0.240 |
Why?
|
Poaceae | 1 | 2004 | 25 | 0.230 |
Why?
|
Pollen | 1 | 2004 | 80 | 0.220 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2004 | 104 | 0.220 |
Why?
|
Hypersensitivity, Immediate | 1 | 2006 | 347 | 0.220 |
Why?
|
Plant Extracts | 1 | 2004 | 498 | 0.170 |
Why?
|
Desensitization, Immunologic | 1 | 2004 | 556 | 0.150 |
Why?
|
Allergy and Immunology | 1 | 2018 | 176 | 0.130 |
Why?
|
Asthma | 2 | 2006 | 6234 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2018 | 547 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2000 | 1171 | 0.090 |
Why?
|
Allergens | 2 | 2006 | 1432 | 0.070 |
Why?
|
Bronchoconstrictor Agents | 1 | 2006 | 77 | 0.070 |
Why?
|
Bronchial Provocation Tests | 1 | 2006 | 216 | 0.070 |
Why?
|
Methacholine Chloride | 1 | 2006 | 220 | 0.070 |
Why?
|
Immunotherapy | 1 | 2000 | 4652 | 0.060 |
Why?
|
Administration, Sublingual | 1 | 2004 | 59 | 0.060 |
Why?
|
Skin Tests | 1 | 2006 | 637 | 0.060 |
Why?
|
Capsules | 1 | 2004 | 191 | 0.050 |
Why?
|
Inhalation Exposure | 1 | 2006 | 432 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 7967 | 0.050 |
Why?
|
Interleukin-3 | 2 | 1994 | 425 | 0.050 |
Why?
|
Seasons | 1 | 2004 | 1520 | 0.040 |
Why?
|
Online Systems | 1 | 2018 | 182 | 0.040 |
Why?
|
Information Systems | 1 | 2018 | 396 | 0.030 |
Why?
|
Administration, Oral | 1 | 2004 | 4021 | 0.030 |
Why?
|
Receptors, Interleukin-3 | 1 | 1994 | 29 | 0.030 |
Why?
|
Access to Information | 1 | 2018 | 316 | 0.030 |
Why?
|
Genes, Regulator | 1 | 1994 | 373 | 0.030 |
Why?
|
Information Dissemination | 1 | 2018 | 1126 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2004 | 12341 | 0.020 |
Why?
|
Alternative Splicing | 1 | 1994 | 1093 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 1994 | 5789 | 0.020 |
Why?
|
Child | 2 | 2006 | 80153 | 0.020 |
Why?
|
Risk Assessment | 1 | 2006 | 23995 | 0.010 |
Why?
|
Cohort Studies | 1 | 2006 | 41487 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 5486 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1994 | 7594 | 0.010 |
Why?
|
Gene Expression | 1 | 1993 | 7581 | 0.010 |
Why?
|
DNA | 1 | 1993 | 7212 | 0.010 |
Why?
|
Humans | 6 | 2018 | 761504 | 0.010 |
Why?
|
Base Sequence | 3 | 1994 | 12441 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2004 | 64680 | 0.010 |
Why?
|
Molecular Sequence Data | 3 | 1994 | 17635 | 0.010 |
Why?
|
Cell Line | 3 | 1994 | 15601 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 1993 | 9606 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1993 | 10194 | 0.010 |
Why?
|
Ribonucleases | 1 | 1994 | 277 | 0.010 |
Why?
|
Deoxyribonuclease BamHI | 1 | 1993 | 17 | 0.010 |
Why?
|
Octamer Transcription Factor-1 | 1 | 1993 | 30 | 0.010 |
Why?
|
Host Cell Factor C1 | 1 | 1993 | 35 | 0.010 |
Why?
|
Transcription Factors | 1 | 1993 | 12128 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1994 | 347 | 0.010 |
Why?
|
DNA Primers | 1 | 1994 | 2819 | 0.010 |
Why?
|
United States | 1 | 2018 | 72334 | 0.010 |
Why?
|
Middle Aged | 1 | 2004 | 220895 | 0.010 |
Why?
|
Adult | 1 | 2004 | 221177 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1994 | 4174 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1993 | 790 | 0.010 |
Why?
|
Male | 1 | 2004 | 360804 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1993 | 6132 | 0.000 |
Why?
|
Female | 1 | 2004 | 392644 | 0.000 |
Why?
|
Leukemia | 1 | 1993 | 1522 | 0.000 |
Why?
|
Binding Sites | 1 | 1993 | 6055 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1994 | 13446 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1994 | 12795 | 0.000 |
Why?
|
Animals | 2 | 1994 | 168459 | 0.000 |
Why?
|
Mice | 1 | 1994 | 81525 | 0.000 |
Why?
|